As of 4:00pm ET
| -0.48 / -3.11%|
The 6 analysts offering 12-month price forecasts for Insmed Inc have a median target of 21.00, with a high estimate of 35.00 and a low estimate of 14.00. The median estimate represents a +40.47% increase from the last price of 14.95.
The current consensus among 7 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.